DiaMedica Therapeutics (DMAC) Operating Leases (2019 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Operating Leases of $96000.0 for Q1 2026, down 52.24% year-over-year from $201000.0 in Q1 2025, and down 22.58% quarter-over-quarter from $124000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Operating Leases (2019 - 2026) Analysis & Trends
DiaMedica Therapeutics' Operating Leases history runs 8 years deep, the most recent figure standing at $96000.0 for Q1 2026.
- In Q1 2026, Operating Leases fell 52.24% year-over-year to $96000.0; the TTM figure through Mar 2026 stood at $96000.0 (down 52.24% YoY), while the FY2025 annual figure was $124000.0, down 44.89% from the prior year.
- Operating Leases for Q1 2026 stood at $96000.0, down from $124000.0 in the prior quarter.
- The five-year high for Operating Leases was $459000.0 in Q3 2022, with the low at $4000.0 in Q2 2023.
- The 5-year median for Operating Leases is $316000.0 (2023), against an average of $273705.9.
- The sharpest annual moves came in 2022 and 2023: Operating Leases jumped 13100.0% in 2022, then slumped 99.1% in 2023.
- DiaMedica Therapeutics' Operating Leases stood at $396000.0 in 2022, then fell by 20.2% to $316000.0 in 2023, then fell by 28.8% to $225000.0 in 2024, then sank by 44.89% to $124000.0 in 2025, then retreated by 22.58% to $96000.0 in 2026.
- Business Quant data shows DMAC's Operating Leases at $96000.0 in Q1 2026, $124000.0 in Q4 2025, and $150000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 176,000.00 |
| Mar 31, 2026 | 96,000.00 |
| Dec 31, 2025 | 124,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 272,000.00 |
| Mar 31, 2025 | 201,000.00 |
| Dec 31, 2024 | 225,000.00 |
| Sep 30, 2024 | 337,000.00 |
| Jun 30, 2024 | 357,000.00 |
| Mar 31, 2024 | 377,000.00 |
| Dec 31, 2023 | 316,000.00 |
| Sep 30, 2023 | 415,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 450,000.00 |
| Dec 31, 2022 | 396,000.00 |
| Sep 30, 2022 | 459,000.00 |
| Jun 30, 2022 | 446,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 60,000.00 |